Lantheus Medical Imaging

Lantheus is a global leader in the field of medical imaging. We develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Our pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.

Our products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases.

In addition to our diversified portfolio of commercialized imaging agents and products, we have a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Type
Public
HQ
Billerica, US
Founded
1956
Employees
474 (est)
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Locations

Billerica, US
Montréal, CA

Lantheus Medical Imaging Metrics

Lantheus Medical Imaging Summary

Market capitalization

$332 M

Closing share price

$9.55
Lantheus Medical Imaging's latest market capitalization is $332 M.

Lantheus Medical Imaging Market Value History

Lantheus Medical Imaging News

Lantheus Medical Imaging Company Life

You may also be interested in